Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keke Wang
Observed name:
K R Wang
Institution:
China-US (Henan) Hormel Cancer Institute
Observed institutions:
Beijing Normal University,
Zhengzhou University,
Yangzhou Polytechnic Institute,
China-US (Henan) Hormel Cancer Institute
ORCID:
0000-0001-9256-2999
Observed ORCID:
0000-0001-9256-2999
OpenAlex ID:
A5108974306
Chronic stress–induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy response
2025
·
Ting Wang
, Xiangyu Wang
, et al.
·
Proceedings of the National Academy of Sciences
·
18
Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
·
Cancer Research
·
18
Figure S5+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
Figure S7+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
Figure S6+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
Figure S1+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
Figure S3+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
Figure S4+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
Figure S2+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Liting Zhou
, Jie Tian
, et al.
INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma
2026
·
Xiangyu Wang
, Ting Wang
, et al.
·
Nature Communications
A bibliometric assessment of research trends and emerging themes at the nexus of chemotherapy and depression
2025
·
Keke Wang
, Qing Chen
, et al.
·
Naunyn-Schmiedeberg s Archives of Pharmacology
Figure S6+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S1+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
PDF
Figure S2+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S7+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S5+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S4+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Table S1, S2, S3 from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S3+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Data from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S6+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S7+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S4+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Figure S1+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
PDF
Figure S3+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024
·
Liting Zhou
, Jie Tian
, et al.
Show more works
View as search
Works count:
29
Citation count:
36
H-index:
2
I10-index:
2
Year
Topic
Type
